Testa, S.; Bui, N.Q.; Wang, D.S.; Louie, J.D.; Sze, D.Y.; Ganjoo, K.N.
Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas. Cancers 2022, 14, 324.
https://doi.org/10.3390/cancers14020324
AMA Style
Testa S, Bui NQ, Wang DS, Louie JD, Sze DY, Ganjoo KN.
Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas. Cancers. 2022; 14(2):324.
https://doi.org/10.3390/cancers14020324
Chicago/Turabian Style
Testa, Stefano, Nam Q. Bui, David S. Wang, John D. Louie, Daniel Y. Sze, and Kristen N. Ganjoo.
2022. "Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas" Cancers 14, no. 2: 324.
https://doi.org/10.3390/cancers14020324
APA Style
Testa, S., Bui, N. Q., Wang, D. S., Louie, J. D., Sze, D. Y., & Ganjoo, K. N.
(2022). Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas. Cancers, 14(2), 324.
https://doi.org/10.3390/cancers14020324